ERBB2 and neoplasm: On the contrary, both perforin- and C3-mediated mechanisms, including ADCC, CDCC, and antibody-dependent cellular phagocytosis (ADCP), provide partial but significant support to the anti-tumor effect exerted by anti-Her2 antibodies.